Illumina INC:1107104 [17-059556]

Ended Purchase Order Awarded Last action

Contract number
HHSN261201700591P
Awardee
Awarding agency
Obligated
$20,987

Award facts

Contract value 100% obligated
$20,987.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
811219 Other Electronic and Precision Equipment Repair and Maintenance
PSC
J066 Maint/Repair/Rebuild Of Equipment- Instruments And Laboratory Equipment
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded a purchase order to Illumina, Inc. for $20,987.00 on August 31, 2017, with final completion scheduled for March 19, 2018. Performance takes place in Bethesda, Maryland. The order covers sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product portfolio for federal genomic research applications. Pricing is firm fixed price with no set-aside applied.

Quick answers

Who was awarded contract HHSN261201700591P?

HHSN261201700591P was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2017.

How much is contract HHSN261201700591P worth?

The government has obligated $20,987 on HHSN261201700591P.

Was contract HHSN261201700591P competed?

The extent of competition for HHSN261201700591P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award